Defining Limits of Treatment with Humanized Neutralizing Monoclonal Antibody for West Nile Virus Neurological Infection in a Hamster Model
about
Neurological approaches for investigating West Nile virus disease and its treatment in rodentsWest Nile virus–induced acute flaccid paralysis is prevented by monoclonal antibody treatment when administered after infection of spinal cord neuronsEfficacy of orally administered T-705 pyrazine analog on lethal West Nile virus infection in rodentsThe structural immunology of antibody protection against West Nile virusPersistent West Nile Virus Associated with a Neurological Sequela in Hamsters Identified by Motor Unit Number EstimationMolecular mechanisms of antibody-mediated neutralisation of flavivirus infectionStructural Insights into the Mechanisms of Antibody-Mediated Neutralization of Flavivirus Infection: Implications for Vaccine DevelopmentA Therapeutic Antibody against West Nile Virus Neutralizes Infection by Blocking Fusion within EndosomesHuman Monoclonal Antibodies against West Nile Virus Induced by Natural Infection Neutralize at a Postattachment StepProgress on the development of therapeutics against West Nile virusComplement Protein C1q Reduces the Stoichiometric Threshold for Antibody-Mediated Neutralization of West Nile VirusThe Development of Therapeutic Antibodies That Neutralize Homologous and Heterologous Genotypes of Dengue Virus Type 1Neurological suppression of diaphragm electromyographs in hamsters infected with West Nile virus.North American encephalitic arbovirusesSafety and pharmacokinetics of single intravenous dose of MGAWN1, a novel monoclonal antibody to West Nile virus.Autonomic nervous dysfunction in hamsters infected with West Nile virus.Inhibition of West Nile virus by calbindin-D28k.Respiratory insufficiency correlated strongly with mortality of rodents infected with West Nile virus.West Nile virus preferentially transports along motor neuron axons after sciatic nerve injection of hamsters.Immune correlates of protection against yellow fever determined by passive immunization and challenge in the hamster model.A preliminary randomized double blind placebo-controlled trial of intravenous immunoglobulin for Japanese encephalitis in Nepal.A humanized IgG but not IgM antibody is effective in prophylaxis and therapy of yellow fever infection in an AG129/17D-204 peripheral challenge mouse modelExperimental therapies for yellow feverA game of numbers: the stoichiometry of antibody-mediated neutralization of flavivirus infection.West Nile virus drug discovery.Vaccines and immunotherapeutics for the prevention and treatment of infections with West Nile virus.An Overview of Current Approaches Toward the Treatment and Prevention of West Nile Virus Infection.Genotype-specific neutralization and protection by antibodies against dengue virus type 3.Noninvasive bioluminescence imaging of dengue virus infection in the brain of A129 mice.Treatment of spatial memory impairment in hamsters infected with West Nile virus using a humanized monoclonal antibody MGAWN1.
P2860
Q27009096-8160974B-E250-4EFB-8AFA-8D48FAA48B28Q27487333-1BE3BDC2-E681-4FB4-827B-89D08ADBB400Q27487357-DBD259AB-7C19-4FA2-B002-D663504E23EAQ27487955-DC1C29EB-62F0-40C5-B341-9B21ECC8DB58Q27488303-6BCC16CD-91C6-4457-BD85-55051A8069C2Q27488337-CCE47D11-5507-4F29-A538-33E753F5C918Q27488364-9980E9FB-9565-43A2-A008-7E84A8AF9F52Q27488367-FFF7E073-6C54-4C21-9BBC-09E42B3B6EA7Q27488791-4208BD54-F99A-4486-AADB-E4B8633DC1A3Q27489893-D178B06E-5522-4953-9881-D5362DF94219Q27490423-F9582642-6A1A-4A82-8987-F9DF0045C622Q27491317-F9875D4A-D45E-46E3-8684-0A59D59CD909Q30474961-8DE54747-BAF3-44E1-9FC9-5CAC180D7D89Q33835377-0BB5EDCF-5402-423F-96B7-DF88611BB4EDQ33876476-9CA70606-F66D-40EC-9EF6-E084EB0E4D1FQ33900339-A20CA5E7-55A4-4A1D-9C3F-069AFD502C22Q34122546-D9CCEBAA-7C9D-4C9D-878A-1F0035841D8EQ34311960-69BCB790-C7FC-4EDE-9092-6BDA0A3322ABQ35016305-C30F4F39-A22B-4344-A148-EF877EFFD978Q35141448-77E9F165-8BC2-46D5-B332-E59574E35C76Q35464299-8C00ABB2-2485-4175-8367-5CEBCFC7858EQ35903209-E0664669-A820-49CF-AAF4-6D8EE8CF40C8Q36586306-00AFDBE3-C0C1-499B-9ED2-402EC5E23F3AQ37012203-433A05DD-B615-452D-9657-63BA63C3CA21Q37666750-EE3C2F01-7D5B-497E-A267-A0C6AE161288Q37842337-AD169FDD-5556-4A34-9CEE-7C2B0EAAE06AQ38866173-E1DF2CC3-EB1A-436E-82DB-EF034F4463AAQ39668466-881085C4-40F7-4416-AD0E-97519057A382Q40255275-14E30144-A9C8-4CEE-8C2C-25D8F2075249Q40325658-C046A3B3-3174-4F97-B8E7-48F062BDE5AB
P2860
Defining Limits of Treatment with Humanized Neutralizing Monoclonal Antibody for West Nile Virus Neurological Infection in a Hamster Model
description
2007 nî lūn-bûn
@nan
2007 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
Defining Limits of Treatment w ...... l Infection in a Hamster Model
@ast
Defining Limits of Treatment w ...... l Infection in a Hamster Model
@en
Defining Limits of Treatment w ...... l Infection in a Hamster Model
@nl
type
label
Defining Limits of Treatment w ...... l Infection in a Hamster Model
@ast
Defining Limits of Treatment w ...... l Infection in a Hamster Model
@en
Defining Limits of Treatment w ...... l Infection in a Hamster Model
@nl
prefLabel
Defining Limits of Treatment w ...... l Infection in a Hamster Model
@ast
Defining Limits of Treatment w ...... l Infection in a Hamster Model
@en
Defining Limits of Treatment w ...... l Infection in a Hamster Model
@nl
P2093
P2860
P50
P356
P1476
Defining Limits of Treatment w ...... l Infection in a Hamster Model
@en
P2093
Aaron L Olsen
Jeffery O Hall
Jeffrey L Nordstrom
Justin G Julander
Scott Koenig
Syd Johnson
P2860
P304
P356
10.1128/AAC.00147-07
P407
P577
2007-07-01T00:00:00Z